These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
631 related articles for article (PubMed ID: 27291819)
1. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer. Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819 [TBL] [Abstract][Full Text] [Related]
2. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
3. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
4. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
6. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. Wang K; Chen M; Wu W World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412 [TBL] [Abstract][Full Text] [Related]
7. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767 [TBL] [Abstract][Full Text] [Related]
8. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
10. Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma. Tian F; Li R; Chen Z; Shen Y; Lu J; Xie X; Ge Q Biomed Res Int; 2016; 2016():1428271. PubMed ID: 27247934 [TBL] [Abstract][Full Text] [Related]
11. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
12. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
13. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Wang RJ; Zheng YH; Wang P; Zhang JZ Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772 [TBL] [Abstract][Full Text] [Related]
14. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis. Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822 [TBL] [Abstract][Full Text] [Related]
15. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980 [TBL] [Abstract][Full Text] [Related]
16. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of miR-139-5p in non-small cell lung cancer. Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351 [TBL] [Abstract][Full Text] [Related]
18. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data. Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234 [TBL] [Abstract][Full Text] [Related]
20. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]